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1. Introduction 
The components of modern vaccines often include protein antigens, adjuvants, and excipients. Typically, 
structural information is derived from protein in solution or after desorption from adjuvant, while the analysis of the 
adsorbed antigen in emulsion or suspension is not normally performed. With advancement in technologies for 
protein analysis, there is now a possibility to characterize antigens in adjuvanted form both at concentrations 
intended for a bulk concentrates and for final container. The application of Fourier Transform Infrared Spectroscopy 
(FTIR), Differential Scanning Calorimetry (DSC), and Circular Dichroism (CD) were evaluated to study protein 
antigens in adjuvanted form. SDS-PAGE was found useful to correlate conformational changes with the integrity of 
adjuvanted proteins.  
2. Methods 
2.1. FTIR
Fourier Transformed Infrared Spectroscopy (FTIR) is form of spectroscopy that based on colorimetry of infrared 
(IR) radiation by the sample because of changes in the vibrational states of the molecule. The IR spectrum contains 
absorbance as a function of wavenumber. In ATR-FTIR sampling, the beam of infrared radiation is directed toward 
ATR crystal which has greater refractive index than the sample. The total internal reflection at the sample side of the 
crystal’s surface creates an evanescent wave which penetrates few micrometers into the sample compartment. The 
evanescent wave is reflected back into the ATR crystal and is directed toward the detector inside the 
spectrophotometer.  
FTIR spectroscopy was performed with the use of Vertex 70 FTIR Spectrophotometer equipped with 
cryogenically cooled MCT (mercury-cadmium-telluride) detector and BioATRII sampling accessory. 20μL of 
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sample was injected into the sample cell of the BioATRII. The parameters for spectrum collected at resolution of 4 
cm-1 at constant temperature of 25ºC. Adjuvanted samples are allowed 7 minutes to sediment and stabilize on the 
ATR crystal.  Buffer and sample measurements were conducted; each measurement was composed of 200 scans. 
Data acquisition and analysis was conducted using OPUS 6.5 software (Bruker Optics, Germany). OPUS 
automatically subtracts the background (buffer) spectra from the samples spectra to produce the spectra for the 
analyte.
2.2. DSC
Differential Scanning Calorimetry (DSC) is a thermodynamic technique used to characterize the conformational 
stability of macromolecules in solution.  DSC measures the heat capacity of macromolecules during temperature-
induced transitions, as well as the temperature midpoint of the conformational transition.  DSC also calculates the 
enthalpy (¨H) that maintains the folded tertiary structure at constant pressure and volume.  These parameters 
provide a measurement of the strength of the interactions required to maintain the tertiary structure of the molecule.   
Calorimetric measurements were performed on a Capillary VP-DSC microcalorimeter with autosampler 
(Microcal, Northampton, MA, USA).  Proteins were loaded into the 96 well plate. One at the time, the protein 
samples were loaded automatically into the cell of 0.325 mL volume, and heated at a scan rate of 1°C per minute 
(temperature range from 20°C to 100°C) and at constant pressure of 40 psi. The heat capacity profiles were recorded 
using the VP Viewer, version 1.2 software. The transition temperature and enthalpy of transitions were determined 
using the Microcal Origin version 7.0 software. 
3. Results
The transition temperature of Protein 1 adjuvanted to AlPO4 was greater by 1°C indicative of a more stable 
conformation. However, decreasing in height and broadening of the heat capacity peak indicated that Protein 
1conformation was altered to a somewhat more flexible once adjuvanted to AlPO4. For Protein 2 in AlPO4 only two 
peaks remained out of three-peak transition. Although these two peaks of Protein 2 in AlPO4 had transition 
temperatures of 3°C and 4°C greater than for the first two peaks of Protein 2 in solution, the overall shape and 
height of heat-capacity transition was altered. Similarly to Protein 1, tertiary structure conformation of Protein 2 
became more flexible after adjuvantation to AlPO4. A mixture of Protein 1 and 2 in solution showed altered heat 
capacity profile than simply a sum of two individual heat capacity profiles for each protein. The first peak was a 
summation of the Protein 1 transition peak, and the first transition peak of Protein 2. However, instead of the second 
and third peaks of Protein 2 at only one peak at 80°C was clearly detected for the mixture. Proteins 1 and Protein 2 
analyzed separately or as a mixture showed a significant decrease in enthalpy once adjuvanted to AlOOH, indicative 
of retaining only remnants of the original tertiary structure that unadjuvanted proteins have in solution. As such, the 
enthalpy value of Protein 1 in AlOOH was only 7% of the in-solution enthalpy value, while a mixture of Protein 1 
and 2 in AlOOH showed about 38% of its original enthalpy value.   
Figure 1. DSC analysis of Protein 1 in-solution and in adjuvanted form   
2 0 3 0 4 0 5 0 6 0 7 0 8 0
-5
0
5
1 0
1 5
2 0
2 5
3 0
3 5
4 0
4 5
5 0
5 5
6 0
D ata: T D P 0 01 co n tro l_ cp
M o del: M N 2S tate
C h i^2 /D oF  =  1 .7 9 4E 6
T
m
5 9 .50 ± 0 .0 16
Δ H 2 .2 07 E 5 ± 2 .0 5E 3
Δ H
v
2 .4 12 E 5 ± 2 .8 3E 3
C
p 
(k
ca
l/m
ol
e/
o C
)
T e m p e ra tu re  (oC )
2 0 3 0 4 0 5 0 6 0 7 0 8 0
-5
0
5
1 0
1 5
2 0
2 5
3 0
3 5
4 0
4 5
5 0
5 5
6 0
D ata : P cp A in A L P O 4 0 1 _ cp
M o d el: M N 2 S ta te
C h i^2 /D o F  =  1 .5 1 6 E 7
T m 6 1 .9 9 ± 0 .1 2
Δ H 2 .5 0 2 E 5 ± 8 .6 1 E 3
Δ H
v
1 .1 7 3 E 5 ± 5 .0 1 E 3
C
p 
(k
ca
l/m
ol
e/
o C
)
T e m p e ra tu re  ( oC )
Protein 1in solution Protein 1 in AlPO4
20 30 40 50 60 70 80
-5
0
5
10
15
20
25
30
35
40
45
50
55
60
Data: PcpAALOOH007d_cp
Model: MN2State
Chi^2/DoF = 8.430E6
Tm 55.60 ±1.3
ΔH 1.578E4 ±4.95E3
ΔH
v
9.469E4 ±3.68E4
C
p 
(k
ca
l/m
ol
e/
o C
)
Temperature (oC)
Protein 1 in AlOOH
Marina Kirkitadze et al. / Procedia in Vaccinology 1 (2009) 135–139 137
Figure 2. DSC analysis of Protein 2 in-solution and in adjuvanted form   
Figure 3. DSC analysis of Proteins 1and 2mixture in-solution and in adjuvanted form  
FTIR analysis was applied to determine potential alterations to the secondary structure of Protein 1 after 
adjuvantation to AlPO4 and AlOOH were monitored in the Amide I region of 1700 – 1600 cm-1. Overall shape of 
Amide I region for Protein 1 in solution was similar to that in AlPO4. Additional shoulder that appeared at 1620 cm-
1 indicated the increase in β-sheet content. Alteration of spectral shape, such as disappearance of α-helical portion 
of the spectra in the region of 1660cm-1 to 1650cm-1, and negligible absorbance in Amide I region were indicative 
of a decrease of secondary structure content in Protein 1 as a result of adjuvantation to AlOOH. 
Figure 4. FTIR analysis of Protein 1 in-solution and in adjuvanted form   
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Figure 5. FTIR analysis of Protein 2 in-solution and in adjuvanted form   
FTIR spectra of Protein 2 adjuvanted to AlPO4 had lower intensity than that in solution. Except a small peak in the 
region of 1640cm-1 to 1620cm-1 vector normalized Amide I region of Protein 2 in AlPO4 was almost the same as in 
solution.  Similarly to Protein 1, Protein 2 adjuvanted to AlOOH showed only remnants of the original spectra. A 
closer view showed a distinctive shift of the Amide I spectral region toward 1640cm-1 to 1620cm-1 indicative of 
predominant β-sheet structure in Protein 2 adjuvanted to AlOOH. The Amide I region of the Proteins 1 and 2 
mixture in AlPO4 was equal to the summation of the individual spectra of Protein 1 and Protein 2. As such, the 
shoulder in the region of 1640cm-1 to 1620cm-1 was observed for both proteins in AlPO4. In AlOOH, the mixture 
of Proteins 1 and 2 mixture showed a shift towards β-sheet structure was observed similarly to the Protein 2. In 
terms of concentration limit FTIR with ATR cell was sensitive to collect the spectra of Proteins 1 and 2 mixture in 
solution and adjuvanted to AlPO4 at as low as 50 μg/ml.  
Figure 6. FTIR analysis of Protein 1 and 2 in-solution and in adjuvanted form   
4. Conclusions 
This study evaluated the effect of aluminium phosphate and aluminium oxyhydroxide adjuvants on tertiary and 
secondary structure, and stability of protein antigens. The DSC results demonstrate for each aluminium salt a 
distinctive signature profile, showing alterations in tertiary structure of antigens after adjuvantation. Similarly, FTIR 
spectra demonstrate alteration of secondary structure towards an increase of beta-sheet once the antigens were 
adjuvanted to aluminium oxyhydroxide. The overall conclusion is that a combination of DSC and FTIR showed 
insights into conformational and stability of changes of protein antigens after adjuvantation.  
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